Skip to main content
. 2022 May 18;14(2):423–436. doi: 10.3390/neurolint14020035

Table 3.

Summary of studies regarding pain and psilocybin.

Author (y) Groups Studied and Interventions Results and Findings Conclusions
Johnson et al. (2012)
[53]
18 healthy volunteers were randomly selected to receive either escalating or de-escalating doses of psilocybin (0, 5, 10, 20, 30 mg) over 5 total, 8 h long sessions. Mean onset of headache was 7.0 h after administration.
The number of participants who reported a headache increased as the dose increased, with nearly all reporting headaches at 30mg.
Psilocybin causes headaches in a dose-related fashion.
Ramachandran et al. (2018)
[54]
Case report of a patient who had intractable phantom limb pain after amputation described as a nail boring into the leg. Psilocybin was paired with MVF, where a nail was visualized by the patient being removed from the leg. Psilocybin-MVF worked synergistically to eliminate the pain that felt and decreased any paroxysmal episodes.